Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 6, Issue 21
November 8 2022
Issue Cover

Table of Contents

STIMULUS REPORTS

MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
Matteo Claudio Da Vià,Marta Lionetti,Alessio Marella,Antonio Matera,Erica Travaglino,Elena Signaroldi,Alessia Antonella Galbussera,Ugo Lucca,Sara Mandelli,Emma Riva,Mauro Tettamanti,Loredana Pettine,Alessandra Pompa,Luca Baldini,Antonino Neri,Matteo Giovanni Della Porta,Niccolò Bolli
View Articletitled, MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
Supplemental data
Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
Shanna L. White,Thomas D. Lee,Traci Toy,Judith E. Carroll,Lilian Polsky,Beatriz Campo Fernandez,Alejandra Davila,Donald B. Kohn,Vivian Y. Chang
View Articletitled, Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants

CLINICAL TRIALS AND OBSERVATIONS

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
Clinical Trials & Observations
Aimee C. Talleur,Amr Qudeimat,Jean-Yves Métais,Deanna Langfitt,Ewelina Mamcarz,Jeremy Chase Crawford,Sujuan Huang,Cheng Cheng,Caitlin Hurley,Renee Madden,Akshay Sharma,Ali Suliman,Ashok Srinivasan,M. Paulina Velasquez,Esther A. Obeng,Catherine Willis,Salem Akel,Seth E. Karol,Hiroto Inaba,Allison Bragg,Wenting Zheng,Sheng M. Zhou,Sarah Schell,MaCal Tuggle-Brown,David Cullins,Sagar L Patil,Ying Li,Paul G. Thomas,Caitlin Zebley,Benjamin Youngblood,Ching-Hon Pui,Timothy Lockey,Terrence L. Geiger,Michael M. Meagher,Brandon M. Triplett,Stephen Gottschalk
View Articletitled, Preferential expansion of CD8<sup>+</sup> CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
Supplemental data
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
Clinical Trials & Observations
Andreas Reiter,Juliana Schwaab,Daniel J. DeAngelo,Jason Gotlib,Michael W. Deininger,Kristen M. Pettit,Iván Alvarez-Twose,Alessandro M. Vannucchi,Jens Panse,Uwe Platzbecker,Olivier Hermine,Ingunn Dybedal,Hui-Min Lin,Svetlana N. Rylova,Katrin Ehlert,Saša Dimitrijević,Deepti H. Radia,on behalf of the EXPLORER and PATHFINDER study investigators
View Articletitled, Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
Supplemental data
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
Clinical Trials & Observations
Saar Gill,Vanessa Vides,Noelle V. Frey,Elizabeth O. Hexner,Susan Metzger,Megan O'Brien,Wei-Ting Hwang,Jennifer L. Brogdon,Megan M. Davis,Joseph A. Fraietta,Avery L. Gaymon,Whitney L. Gladney,Simon F. Lacey,Anne Lamontagne,Anthony R. Mato,Marcela V. Maus,J. Joseph Melenhorst,Edward Pequignot,Marco Ruella,Maksim Shestov,John C. Byrd,Stephen J. Schuster,Donald L. Siegel,Bruce L. Levine,Carl H. June,David L. Porter
View Articletitled, Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
Supplemental data

LYMPHOID NEOPLASIA

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
Simon Crouch,Daniel Painter,Sharon L. Barrans,Eve Roman,Philip A. Beer,Susanna L. Cooke,Paul Glover,Suzan J.L. Van Hoppe,Nichola Webster,Stuart E. Lacy,Camilo Ruiz,Peter J. Campbell,Daniel J. Hodson,Russell Patmore,Cathy Burton,Alexandra Smith,Reuben M. Tooze
View Articletitled, Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
Supplemental data
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Pau Abrisqueta,Daniel Medina,Guillermo Villacampa,Junyan Lu,Miguel Alcoceba,Julia Carabia,Joan Boix,Barbara Tazón-Vega,Gloria Iacoboni,Sabela Bobillo,Ana Marín-Niebla,Marcos González,Thorsten Zenz,Marta Crespo,Francesc Bosch
View Articletitled, A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Supplemental data

MYELOID NEOPLASIA

Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset
Martin Böttcher,Konstantinos Panagiotidis,Heiko Bruns,Martina Stumpf,Simon Völkl,Stefanie Geyh,Barbara Dietel,Thomas Schroeder,Andreas Mackensen,Dimitrios Mougiakakos
View Articletitled, Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9<sup>high</sup> AML cell subset
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Malaria-associated adhesion molecule activation facilitates the destruction of uninfected red blood cells
Jill J. Dalimot,Thomas R. L. Klei,Boukje M. Beuger,Zeynep Dikmen,Suzan A. M. Bouwman,Ghyslain Mombo-Ngoma,Rella Zoleko-Manego,Wilfrid F. Ndzebe-Ndoumba,Stéphane Egée,Taco W. Kuijpers,Martin P. Grobusch,Robin van Bruggen
View Articletitled, Malaria-associated adhesion molecule activation facilitates the destruction of uninfected red blood cells
Supplemental data

TRANSPLANTATION

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
Clinical Trials & Observations
Jennifer S. Whangbo,Sarah Nikiforow,Haesook T. Kim,Jonathan Wahl,Carol G. Reynolds,Sharmila C. Rai,Soomin Kim,Andrew Burden,Ana C. Alho,João F. Lacerda,Edwin P. Alyea, III,Corey S. Cutler,Vincent T. Ho,Joseph H. Antin,Robert J. Soiffer,Jerome Ritz,John Koreth
View Articletitled, A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
Supplemental data

RESEARCH LETTERS

CLL-IPI applied in Binet A CLL: a nationwide cohort study
Emelie C. Rotbain,Caspar da Cunha-Bang,Christian Brieghel,Carsten U. Niemann
View Articletitled, CLL-IPI applied in Binet A CLL: a nationwide cohort study
Supplemental data
Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist
Erin Watson,Chandrika Sanapala,Ashley-Marie Cortes,Heidi D. Klepin,Marsha Wittink,Sally Norton,Daniel R. Richardson,William Dale,Allison Magnuson,Jason H. Mendler,Jane Liesveld,Eric Huselton,Kristen O’Dwyer,Thomas W. LeBlanc,Areej El-Jawahri,Melisa L. Wong,Kah Poh Loh
View Articletitled, Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist
Supplemental data
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative
Hiroshi Azuma,Toraji Amano,Naoya Kamiyama,Naofumi Takehara,Maki Jingu,Harumi Takagi,Osamu Sugita,Naoko Kobayashi,Tomoko Kure,Taro Shimizu,Tatsuhiro Ishida,Masanori Matsumoto,Hiromi Sakai
View Articletitled, First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative
Supplemental data

ERRATUM

Buettner R, Morales C, Caserta E, et al. Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting. Blood Adv. 2019;3(7):1027-1032.
View Articletitled, Buettner R, Morales C, Caserta E, et al. Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting. <em>Blood Adv</em>. 2019;3(7):1027-1032.
All Issues

Advertisement intended for health care professionals

Time to revisit reduced-dose radiotherapy for PCNSL?
Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.
Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
Retreatment of multiple myeloma with previously refractory drugs

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals